-
Gastroesophageal Junction Carcinoma Treatment Market: Future Perpective and Its Associative Approach
Nov 8, 2016, 05:41 AM by Michael CroftALBANY, NY, UNITED STATES - Nov 8, 2016 - Gastroesophageal (GE) junction carcinoma is a type of cancer that develops between the esophagus and the tube that connects the stomach with the mouthFull story -
TECHNIDATA, a leading global supplier of software solutions for clinical laboratories and biobanks, strengthens its expansion in the Middle East region and announces the signature of a distribution ag
Nov 8, 2016, 03:45 AM by Michael CroftMONTBONNOT, FRANCE - Nov 8, 2016 - An international growth strategyFull story
With corporate headquarters based in France, regional headquarters in Montreal and Manila to address the North American and Asia-Pacific markets, as well as subsidiaries in Benelux, France, Germany and UK, TECHNIDATA has clearly developed an international expansion strategy -
Diabetes Testing is the Largest Biosensors Market in Medical Applications
Nov 8, 2016, 02:59 AM by Michael CroftALBANY, NY, UNITED STATES - Nov 8, 2016 - Biosensors are the devices used for the detection of analyte and combines physiological detector with biological componentsFull story -
BOC Sciences Published New Chemicals with Rare Access
Nov 8, 2016, 01:02 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Nov 8, 2016 - BOC Sciences is under tight construction on its inhibitor and main products. Till present, good feedback like searching being facilitated has been reflected from regular customers, by which the company is much more motivated to build the site a better online shop for chemicalsFull story -
Understanding Africas Diverse Gene Pool Can Help Fight Lifestyle Diseases
Nov 7, 2016, 10:41 AM by Michael CroftThe Conversation | Cracking genetic responses to the changing environment in Africa would open a new frontier in the drive against rising non-communicable diseases on the continent.Full story -
Geriatric Population Rise makes Long Term Care Market to Grow Steadily
Nov 7, 2016, 06:10 AM by Michael CroftALBANY, NY, UNITED STATES - Nov 7, 2016 - Long term care (LTC) service contains a variety of services provided by nursing homes, day care centres, home health agencies and from family or friendsFull story -
Equine Veterinary Services Market is Observed to be a Multi-Billion Dollar Industry
Nov 7, 2016, 05:07 AM by Michael CroftALBANY, NY, UNITED STATES - Nov 7, 2016 - Global equine veterinary market is observed to be a multi-billion dollar industry that consists of various equine activities such as horse racing, competitive riding and leisureFull story -
Supercomputing the p53 Protein as a Promising Anticancer Therapy
Nov 4, 2016, 16:14 PM by Michael CroftTexas Advanced Computing Center | Computational biophysicist Rommie Amaro is using the Stampede supercomputer at TACC to model the largest atomic level system of the tumor suppression protein p53 to date - over 1.5 million atoms. The simulations identify new "pockets" to reactivate p53 which would be a tremendous boost for future anti-cancer drug discovery.Full story -
Tackling the Organizational Challenges Slowing Biotech
Nov 4, 2016, 13:20 PM by Michael CroftFull storyBio-IT World “How do you change the way scientists operate in a fundamental way to win them over?” Matthew Trunnell, CIO at the Fred Hutchinson Cancer Institute, asked the crowd at the Converged IT Summit* last week in San Diego during his opening keynote. While there were plenty of the talks wading into the weeds of how to build and structure data centers, much of the conversation at the Summit tackled the more amorphous problems plaguing bio-IT today: building a community that shares data and incentivizes collaboration.
-
Weill Cornell Medicine and the New York Genome Center Awarded NCI Grant to Create Genomic Data Center
Nov 3, 2016, 11:15 AM by Michael CroftFull storyBio-IT World News Brief | Weill Cornell Medicine and the New York Genome Center were recently awarded a federal grant from the National Cancer Institute to support a joint cancer genomics data center for the research and clinical interpretation of tumors. The grant will provide funding of $490,000 per year over the next five years.
-
Flatiron Health And Foundation Medicine Partner To Launch Clinico-Genomic Database
Nov 3, 2016, 09:53 AM by Michael CroftDiagnostics World News | Flatiron and Foundation Medicine today announced the launch of a clinico-genomic database designed to help researchers and biopharmaceutical partners accelerate the development of targeted therapeutics and immunotherapies to treat cancer. the clinico-genomic database, containing information on nearly 20,000 patients, is one of the largest and most comprehensive information efforts of its kind in oncology.Full story -
New Data Show Power Limits of Bluebird’s Gene Therapy For Blood Diseases
Nov 3, 2016, 09:48 AM by Michael CroftXconomy | Bluebird Bio is releasing new data this morning that speak to both the potential and the limitations of a gene therapy it's been developing for two deadly blood diseases: sickle cell disease and beta-thalassemia.Full story -
The Pistoia Alliance Calls for Greater Collaboration on Wearable Devices in R&D
Nov 2, 2016, 09:43 AM by Michael CroftLONDON, UNITED KINGDOM - Nov 2, 2016 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, is calling on the pharmaceutical industry to support greater collaboration around wearable device initiativesFull story -
Recipharm invests in its Italian API facility
Nov 2, 2016, 07:14 AM by Michael CroftPADERNO DUGNANO, ITALY - Nov 2, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced an investment of over €1Full story -
Repositive Announce Launch of Microbiome Data Collection
Nov 2, 2016, 05:34 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Nov 2, 2016 - Repositive, a software company developing novel tools to improve discovery and access to human genomic research data, has expanded its Specialised Data Collections, with the addition of microbiome dataFull story -
Optibrium And Collaborative Drug Discovery Integrate StarDrop With CDD Vault
Nov 1, 2016, 15:35 PM by Michael CroftFull storyBio-IT World News Brief | Optibrium and Collaborative Drug Discovery announced a collaboration to integrate the StarDrop and CDD Vault platforms. This creates a connection in real time between project data, securely held and managed in CDD Vault, and StarDrop’s unique compound design and optimization capabilities.
-
Young Scientists Ditch Postdocs for Biotech Start-Ups
Nov 1, 2016, 12:01 PM by Michael CroftNature News & Comment | Many biologists are founding their own firms as venture capitalists show increased interest in science.Full story -
Danforth Plant Science Center Develops Versatile Field Phenotyping to Benefit Farmers
Nov 1, 2016, 11:54 AM by Michael CroftST. LOUIS, MO, UNITED STATES - Nov 1, 2016 - Solar-powered PheNode is set for investment stage.Researchers at the Donald Danforth Plant Science Center, a not-for-profit research institute with a mission to improve the human condition through plant science, are leveraging expertise in crop phenotyping with the development of the PheNode, a 'smart', farm-ready, solar-powered environmental sensor and phenotyping station for cropsFull story -
FactBio Announces Improvements to the Kusp Data Curation Platform
Nov 1, 2016, 05:55 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Nov 1, 2016 - FactBio, has launched Kusp 1.1, an update to its data curation platform which sees a number of new key features addedFull story -
Smarter ELNs and Smarter Labs Make for Smarter Science
Oct 31, 2016, 16:10 PM by Michael CroftFull storyBio-IT World | New technology, new laws and regulations, and more cumbersome "Big Data" have together caused the standard, traditional electronic lab notebook (ELN) to obsolesce. But some experts believe new digital-transformation technology—including the Internet of Things and cloud computing—will allow for enhanced ELNs that can address today's clinical pain points of efficiency, ROI, scientific contextual consistency, and risk reduction.